Skip to main content

Marc Simo Perdigo

Institutions of which they are part

Molecular Medical Imaging
Vall Hebron Institut de Recerca

Marc Simo Perdigo

Institutions of which they are part

Molecular Medical Imaging
Vall Hebron Institut de Recerca

Projects

Incorporación de métodos de imagen y perfiles moleculares para mejorar el cribado de cáncer de próstata en portadores de mutaciones en genes de las vías de reparación de ADN.

IP: Olga Méndez Fernández
Collaborators: Berta Miró Cau, Marc Simo Perdigo, David Ruiz Casajuana, Jacques Planas Morin, Richard Mast
Funding agency: Instituto de Salud Carlos III
Funding: 127500
Reference: PI23/01310
Duration: 01/01/2024 - 31/12/2026

SGR

IP: José Raul Herance Camacho
Collaborators: Jorge Guillermo Romero Farina, Cristina Gamez Cenzano, Amparo García Burillo, Sergio Lopez Gandul, Joan Barbeta Sanchez, Manuel Escobar Amores, Ignacio Navales Mateu, SGR, SGR, Ana Maria Rodriguez Arana, Nuria Roson Gradaille, Eduard Albuixech Ginesta, Mª Carmen López Arribas, Xavier Serres Créixams, Mireia Iniesta Ambrós, Marc Simo Perdigo, Carles Lorenzo Bosquet, Carolina Aparicio Gomez, Alberto Roque Pérez, Queralt Martin Saladich, Gemma Burcet Rodríguez, Lluis Gabalda Martinez, Carmen Sanchez Suarez, Julia Baguña Torres, Esperanza Medina Gutierrez, Hug Cuellar Calabria, Daniel Eiroa Gutierrez, SGR, Maria Teresa Veintemillas Araiz, Alvaro Jesus Valverde Moya, Maria Nazarena Pizzi, Mª Jose Moreno Negrete
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 01284
Duration: 01/01/2022 - 30/06/2025

Grups de recerca en Imatge Mèdica Molecular

IP: José Raul Herance Camacho
Collaborators: Joan Castell Conesa, Amparo García Burillo, Manuel Escobar Amores, Gemma Cuberas Borros, Grups de recerca en Imatge Mèdica Molecular, Roso Marès Pagès, Marc Simo Perdigo, Carles Lorenzo Bosquet, Maria Nazarena Pizzi
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 10000
Reference: 2017SGR1303
Duration: 01/01/2017 - 30/09/2021

Estandarización del diagnóstico anatomopatológico y por imagen de los cambios de transformación maligna inicial en neurofibromas de pacientes con Neurofibromatosis tipo 1

IP: Cleofé Romagosa Pérez-Portabell
Collaborators: Jordi Temprana Salvador, Jorge Pérez López, Marc Simo Perdigo
Funding agency: Instituto de Salud Carlos III
Funding: 81070
Reference: PI14/00724
Duration: 01/01/2015 - 31/12/2018

Related news

The device, called Winco USG, is a simulation platform for holistic and integrated training of professionals performing this type of procedure.

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

The team will investigate, in animal models, the benefits of histotripsy, a technique that allows tumors to be destroyed without incision or heat, and hopes to minimize the risks and enhance the efficacy of immunotherapy.

Related professionals

Albert Barberà LLuis

Albert Barberà LLuis

Director/a d'Àrea
External Strategy Directorate
Read more
Judit Amigó Farran

Judit Amigó Farran

Predoctoral researcher
Diabetes and Metabolism
Read more
Alba Rojano Toimil

Alba Rojano Toimil

Predoctoral researcher
Diabetes and Metabolism
Read more
Neus Mongay Ochoa

Neus Mongay Ochoa

Predoctoral researcher
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.